Plato BioPharma, Inc. — Form D
Plato BioPharma, Inc. of WEST LAFAYETTE, IN, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-20. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-10-20
- Form: D
- Accession: 0001104659-21-128007
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 39
- Date of first sale: 2021-10-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-417748
Issuer
- Name: Plato BioPharma, Inc.
- CIK: 0001494188
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 2701 KENT AVE, WEST LAFAYETTE, IN, 47906-1382
- Phone: 3174634527
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Robert Leasure, Jr. | Director | West Lafayette, IN |
| Beth A Taylor | Director | West Lafayette, IN |
| Robert Leasure, Jr. | Executive Officer | West Lafayette, IN |
| Beth A Taylor | Executive Officer | West Lafayette, IN |
| Craig F Plato | Director | Westminster, CO |
| Craig F Plato | Executive Officer | Westminster, CO |
Other filings by this issuer (1)
More